2 months JPMorgan Chase & Co. Increases Dover (NYSE:DOV) Price Target to $212.00 MarketBeat

JPMorgan Chase & Co. lifted their target price on shares of Dover from $210.00 to $212.00 and gave the stock an “overweight” rating in a research report on Friday.

Dover · Dover (DOV) · JPMorgan (JPM) · NYSE · Science

2 months JPMorgan Chase & Co. Increases Dover (NYSE:DOV) Price Target to $212.00 MarketBeat

3 hours ARKK: Use Their Research, Invest Independently Seeking Alpha

7 hours NYSE short interest rose 2.4 percent in mid-December Investing.com

10 hours Toyota Shares Crippled By Industry Challenges 24/7 Wall St.

15 hours The 3-year bear market in home sales is finally over, research firm says. Here’s how to invest for a rebound. Business Insider

16 hours Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick Zacks

16 hours Meta Platforms (META) is a Top-Ranked Momentum Stock: Should You Buy? Zacks

16 hours Here’s Why Jabil (JBL) is a Strong Momentum Stock Zacks

16 hours Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio Zacks

16 hours Why Watts Water (WTS) is a Top Growth Stock for the Long-Term Zacks

16 hours Here’s Why Energizer Holdings (ENR) is a Strong Growth Stock Zacks

16 hours Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term Zacks

16 hours Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick Zacks

16 hours Why Booz Allen Hamilton (BAH) is a Top Growth Stock for the Long-Term Zacks

16 hours Edison International (EIX) is a Top-Ranked Growth Stock: Should You Buy? Zacks

16 hours Why Travelers (TRV) is a Top Growth Stock for the Long-Term Zacks

16 hours Why RPM International (RPM) is a Top Growth Stock for the Long-Term Zacks

16 hours Here’s Why Roper Technologies (ROP) is a Strong Growth Stock Zacks

16 hours Here’s Why Molina (MOH) is a Strong Growth Stock Zacks

16 hours Science Says Don’t Try to Overcome Imposter Syndrome: How Embracing a Self-Perceived Inadequacy Can Make Your Life Better, Starting Today Inc.com

16 hours Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Zacks

16 hours Here’s Why Progressive (PGR) is a Strong Value Stock Zacks

16 hours Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term Zacks

16 hours Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Zacks

16 hours Why Walt Disney (DIS) is a Top Value Stock for the Long-Term Zacks

16 hours Why Encompass Health (EHC) is a Top Value Stock for the Long-Term Zacks

16 hours Why This 1 Value Stock Could Be a Great Addition to Your Portfolio Zacks

16 hours Here’s Why Discover (DFS) is a Strong Value Stock Zacks

16 hours Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Zacks

16 hours Why Allstate (ALL) is a Top Value Stock for the Long-Term Zacks

16 hours Here’s Why Donaldson (DCI) is a Strong Value Stock Zacks

16 hours Wall Street Analysts Think Lam Research (LRCX) Is a Good Investment: Is It? Zacks

17 hours JPMorgan Chase & Co. (JPM) Is a Trending Stock: Facts to Know Before Betting on It Zacks

19 hours Is GTRAX a Strong Bond Fund Right Now? Zacks

19 hours Is PDBZX a Strong Bond Fund Right Now? Zacks

19 hours Is Janus Henderson Research D (JNRFX) a Strong Mutual Fund Pick Right Now? Zacks

20 hours Earth’s orbit is so crowded that space traffic controllers issue more than 1,000 collision warnings per day Business Insider

22 hours Researchers have followed over 700 people since 1938 to find the keys to happiness. Here’s what they discovered Fortune

23 hours Guaranteed basic income isn’t a silver bullet, says the lead researcher behind Sam Altman’s major study Business Insider

1 day MDA Space: Worth A Peer Group Valuation On Space Tech Growth Seeking Alpha

1 day Dow Inc. (DOW) Ascends But Remains Behind Market: Some Facts to Note Zacks

1 day Are These AI Stocks Ready for a Comeback? InvestorPlace

1 day NYSE short interest rose 2.4 percent in mid-December Investing.com

1 day Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks

2 days AI-assisted wildlife surveillance is eavesdropping on endangered spider monkeys Fast Company

2 days Here’s Why You Should Retain Inogen Stock in Your Portfolio Now Zacks

2 days Qualys Trading at a Discount: Is This the Right Time to Buy the Stock? Zacks

2 days FactSet Earnings & Revenues Beat Estimates in Q1, Increase Y/Y Zacks

2 days Scientist says the one thing everyone hates about AI is ultimately what helped him win a Nobel Prize Fortune

2 days Breakthrough T1D Play has raised $5M for diabetes research VentureBeat

2 days Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term Zacks

The Stock Market News